Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.
4 reports, 2 independent
Updated Sep 11
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Morgan Stanley increased its investment stake in Eli Lilly stock, requiring a Form 13F filing with the SEC.1 source
Morgan Stanley increased its stake in Eli Lilly, filing required reports with the SEC.1 source
Keep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Micron Technology, Norges Bank, and Morgan Stanley are involved in stock purchases and increased holdings as of June 26, 2026, requiring SEC filings.
- Cantor Fitzgerald increased its price target on Eli Lilly and Company stock.
- MarketBeat listed Eli Lilly and Company among stocks to watch on October 31, 2026.
- SEC filing reported investment changes involving BLOCK and Morgan Stanley.
- A fund has changed its holdings, replacing JPMorgan Chase with Eli Lilly and Company.